Skip to main content
Top
Published in: Gastric Cancer 4/2016

01-10-2016 | Original Article

Portomesenteric vein thrombosis after gastric surgery

Authors: Ji-Won Han, Seong-Ho Kong, Cheong-il Shin, Seung-Kee Min, Sang-il Min, Tae Han Kim, Jun-Young Yang, Seung-young Oh, Yun-Suhk Suh, Hyuk-Joon Lee, Han-Kwang Yang

Published in: Gastric Cancer | Issue 4/2016

Login to get access

Abstract

Background

Postoperative portomesenteric venous thrombosis (PMVT) is a rare but potentially serious complication of gastric surgery. This study analyzed the incidence, characteristics, risk factors, and outcomes of PMVT following gastric surgery.

Methods

Medical records of patients who underwent gastric surgery between January 2007 and December 2012 were reviewed retrospectively. The risk factors of PMVT were analyzed by a logistic regression analysis with control group matched 1:4 by age, sex, and cancer stage and by a Poisson regression analysis with unmatched control group. The resolution rate of PMVT in 12 months was compared between the treatment group and the nontreatment group.

Results

The total incidence of PMVT after gastric surgery was 0.67 % (31/4611). Most (54.84 %) PMVT cases were detected within 1 month postoperatively. No accompanying deep vein thrombosis (DVT) was noted. Multivariate comparison with 1:4 matched control showed that combined splenectomy, synchronous malignancy, and intra-abdominal complication were independent risk factors. Advanced stage, combined splenectomy, and synchronous malignancy were independent risk factors in Poisson regression analysis using unmatched controls. The resolution rate of PMVT was not different from patients treated with anticoagulation (n = 6) or antiplatelet therapy (n = 1) and were not significantly different with those of the untreated group [85.7 % (6/7) vs. 82.3 % (14/17), p = 0.935] during 1-year follow up.

Conclusions

PMVT after gastric surgery was associated with advanced cancer stage, combined splenectomy, and synchronous malignancy, but it was not related to laparoscopy or DVT. Significant differences in the natural course of PMVT were not found between the treatment group and observation group.
Literature
1.
go back to reference Goitein D, et al. Portomesenteric thrombosis following laparoscopic bariatric surgery: incidence, patterns of clinical presentation, and etiology in a bariatric patient population. JAMA Surg. 2013;148(4):340–6.CrossRef Goitein D, et al. Portomesenteric thrombosis following laparoscopic bariatric surgery: incidence, patterns of clinical presentation, and etiology in a bariatric patient population. JAMA Surg. 2013;148(4):340–6.CrossRef
2.
go back to reference James AW, et al. Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review. Arch Surg. 2009;144(6):520–6.CrossRef James AW, et al. Portomesenteric venous thrombosis after laparoscopic surgery: a systematic literature review. Arch Surg. 2009;144(6):520–6.CrossRef
3.
go back to reference Denne JL, Kowalski C. Portal vein thrombosis after laparoscopic gastric bypass. Obes Surg. 2005;15(6):886–9.CrossRef Denne JL, Kowalski C. Portal vein thrombosis after laparoscopic gastric bypass. Obes Surg. 2005;15(6):886–9.CrossRef
4.
go back to reference Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15(10):1368–74.CrossRef Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg. 2005;15(10):1368–74.CrossRef
5.
go back to reference Gao JS, Wang Z, Wei GH, Song WL, Yi BQ, Gao ZG, et al. Deep vein thrombosis after gastrectomy for gastric carcinoma. World J Gastroenterol. 2009;15(7):885–7.CrossRef Gao JS, Wang Z, Wei GH, Song WL, Yi BQ, Gao ZG, et al. Deep vein thrombosis after gastrectomy for gastric carcinoma. World J Gastroenterol. 2009;15(7):885–7.CrossRef
6.
go back to reference Yang YY, et al. Case report: portal vein thrombosis associated with hereditary protein C deficiency: a report of two cases. J Gastroenterol Hepatol. 1999;14(11):1119–23.CrossRef Yang YY, et al. Case report: portal vein thrombosis associated with hereditary protein C deficiency: a report of two cases. J Gastroenterol Hepatol. 1999;14(11):1119–23.CrossRef
7.
go back to reference Kagawa S, et al. Portal/splenic vein thrombosis following splenectomy in gastric cancer surgery. Asian J Surg. 2010;33(4):208–11.CrossRef Kagawa S, et al. Portal/splenic vein thrombosis following splenectomy in gastric cancer surgery. Asian J Surg. 2010;33(4):208–11.CrossRef
8.
go back to reference Krauth MT, et al. The postoperative splenic/portal vein thrombosis after splenectomy and its prevention–an unresolved issue. Haematologica. 2008;93(8):1227–32.CrossRef Krauth MT, et al. The postoperative splenic/portal vein thrombosis after splenectomy and its prevention–an unresolved issue. Haematologica. 2008;93(8):1227–32.CrossRef
9.
go back to reference Miettinen OS. Individual matching with multiple controls in the case of all-or-none responses. Biometrics. 1969;25(2):339–55.CrossRef Miettinen OS. Individual matching with multiple controls in the case of all-or-none responses. Biometrics. 1969;25(2):339–55.CrossRef
10.
go back to reference Caine GJ, et al. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4(6):465–73.CrossRef Caine GJ, et al. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002;4(6):465–73.CrossRef
11.
go back to reference Heit JA, et al. Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. Thromb Res. 2015;136(2):298–307.CrossRef Heit JA, et al. Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. Thromb Res. 2015;136(2):298–307.CrossRef
12.
go back to reference Gould MK, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians evidence-based clinical practice guidelines, 9th ed. Chest. 2012;141(2 suppl):e227S–77S.CrossRef Gould MK, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians evidence-based clinical practice guidelines, 9th ed. Chest. 2012;141(2 suppl):e227S–77S.CrossRef
13.
go back to reference Freedman J, et al. Testosterone, thrombophilia, thrombosis. Transl Res. 2015;165(5):537–48.CrossRef Freedman J, et al. Testosterone, thrombophilia, thrombosis. Transl Res. 2015;165(5):537–48.CrossRef
14.
go back to reference Glueck CJ, et al. Testosterone therapy, thrombophilia, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study. Med Hypotheses. 2015;84(4):341–3.CrossRef Glueck CJ, et al. Testosterone therapy, thrombophilia, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory, hypothesis-generating study. Med Hypotheses. 2015;84(4):341–3.CrossRef
15.
go back to reference Bang SM, et al. Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci. 2010;25(11):1553–9.CrossRef Bang SM, et al. Korean guidelines for the prevention of venous thromboembolism. J Korean Med Sci. 2010;25(11):1553–9.CrossRef
16.
go back to reference Bang SM, et al. Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis evidence-based clinical practice guidelines. J Korean Med Sci. 2014;29(2):164–71.CrossRef Bang SM, et al. Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis evidence-based clinical practice guidelines. J Korean Med Sci. 2014;29(2):164–71.CrossRef
17.
go back to reference Condat B, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120(2):490–7.CrossRef Condat B, et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120(2):490–7.CrossRef
18.
go back to reference Condat B, et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32(3):466–70.CrossRef Condat B, et al. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology. 2000;32(3):466–70.CrossRef
Metadata
Title
Portomesenteric vein thrombosis after gastric surgery
Authors
Ji-Won Han
Seong-Ho Kong
Cheong-il Shin
Seung-Kee Min
Sang-il Min
Tae Han Kim
Jun-Young Yang
Seung-young Oh
Yun-Suhk Suh
Hyuk-Joon Lee
Han-Kwang Yang
Publication date
01-10-2016
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 4/2016
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-015-0562-4

Other articles of this Issue 4/2016

Gastric Cancer 4/2016 Go to the issue